Who
Andrew Rappaport
Director
Company insider
Files Form 4 as: Director, Olema Pharmaceuticals; Director, Atheros Communications; 10% owner, Seagate Technology Holdings.
In numbers
- Trades disclosed
- 49
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 31 Dec 2005
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,500 at $0.00 | filing |
| 25 Nov 2025filed 25 Nov 2025 | OLMA Olema PharmaceuticalsBiotechnology | SEC FORM 4 Code G | —35,868 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —35,868 at $0.00 | filing |
| 21 Nov 2025filed 25 Nov 2025 | OLMA Olema PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $14K35,868 at $0.39 | filing |
| 11 Jun 2025filed 13 Jun 2025 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,150 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 5 Mar 2024filed 6 Mar 2024 | OLMA Olema PharmaceuticalsBiotechnology | SEC FORM 4 Code J | —481,014 at $0.00 | filing |
| 5 Mar 2024filed 6 Mar 2024 | OLMA Olema PharmaceuticalsBiotechnology | SEC FORM 4 Code J | —385,965 at $0.00 | filing |
| 16 Jun 2023filed 21 Jun 2023 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 17 Jun 2022filed 27 Jun 2022 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 16 Jun 2022filed 17 Jun 2022 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 9 Jun 2021filed 10 Jun 2021 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 23 Nov 2020filed 23 Nov 2020 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code C | —318,723 | filing |
| 23 Nov 2020filed 23 Nov 2020 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code C | —129,833 | filing |
| 23 Nov 2020filed 23 Nov 2020 | OLMA Olema PharmaceuticalsBiotechnology | SEC FORM 4 Code C | —318,723 | filing |
| 23 Nov 2020filed 23 Nov 2020 | OLMA Olema PharmaceuticalsBiotechnology | SEC FORM 4 Code C | —129,833 | filing |
| 18 Nov 2020filed 19 Nov 2020 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,520 at $0.00 | filing |
| 18 Sep 2020filed 19 Nov 2020 | OLMA Olema Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —56,964 at $0.00 | filing |
| 24 May 2011filed 24 May 2011 | Atheros Communicationsoption or derivative | SEC FORM 4 Code D | $245K7,500 at $32.71 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.